AMSBIO announces DNA-In™ Neuro - a new generation transfection reagent developed specifically for maximum nucleic acid delivery into neurons, typically achieving a 2-fold or greater improvement in efficiency over currently available competing reagents.

Neurons are among the most difficult cell types to transfect. DNA-In™ Neuro Transfection Reagent offers researchers a cost effective, robust and easy-to-use DNA delivery solution for transfecting freshly isolated and cryopreserved neurons. DNA-In™ Neuro Transfection Reagent reproducibly transfects neurons and neural stem cells at optimal efficiency with exceptionally low toxicity to support uncompromised post-transfection assays.

Comprising a proprietary formulation of chemically defined compounds, DNA-In™ Neuro Transfection Reagent is completely free of animal-derived components. Designed for use with a quick and easy to follow, single-tube reagent protocol - DNA-In™ Neuro Transfection Reagent produces great results on the very first try.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognised today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO is able to draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective. Custom services include stable cell line production, CRISPR/Cas9 Genome Editing, lentivirus and adenovirus production, large scale protein production and a comprehensive portfolio of antibody services.

more about amsbio

more news from amsbio